ADAR1 Capital Management »

Alexandria Real Estate Equities shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Alexandria Real Estate Equities (ARE) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Alexandria Real Estate Equities

Tip: Access up to 7 years of quarterly data

All positions including Alexandria Real Estate Equities held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alexandria Real Estate Equities by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $798k 16k 48.94

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Alexandria Real Estate Equities

Vanguard Group
BlackRock
Norges Bank Investment Management
State Street Corporation
APG Asset Management US
Invesco
Geode Capital Management
Capital World Investors
Goldman Sachs Group
Jpmorgan Chase & Co
Northern Trust
AQR Capital Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Susquehanna International

View all funds holding Alexandria Real Estate Equities